These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8426364)

  • 1. Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines.
    Nelson ML; Park BH; Andrews JS; Georgian VA; Thomas RC; Levy SB
    J Med Chem; 1993 Feb; 36(3):370-7. PubMed ID: 8426364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular requirements for the inhibition of the tetracycline antiport protein and the effect of potent inhibitors on the growth of tetracycline-resistant bacteria.
    Nelson ML; Park BH; Levy SB
    J Med Chem; 1994 Apr; 37(9):1355-61. PubMed ID: 8176712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein.
    Nelson ML; Levy SB
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1719-24. PubMed ID: 10390229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of tetracyclines into Escherichia coli requires a carboxamide group at the C2 position of the molecule.
    Chopra I
    J Antimicrob Chemother; 1986 Dec; 18(6):661-6. PubMed ID: 3546242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptible Escherichia coli cells can actively excrete tetracyclines.
    McMurry LM; Aronson DA; Levy SB
    Antimicrob Agents Chemother; 1983 Oct; 24(4):544-51. PubMed ID: 6418064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,12-substituted tetracyclines as antioxidant agents.
    Lertvorachon J; Kim JP; Soldatov DV; Boyd J; Roman G; Cho SJ; Popek T; Jung YS; Lau PC; Konishi Y
    Bioorg Med Chem; 2005 Aug; 13(15):4627-37. PubMed ID: 15951186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
    Sum PE; Lee VJ; Testa RT; Hlavka JJ; Ellestad GA; Bloom JD; Gluzman Y; Tally FP
    J Med Chem; 1994 Jan; 37(1):184-8. PubMed ID: 8289194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 9-substituted tetracycline derivatives.
    Koza DJ; Nsiah YA
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2163-5. PubMed ID: 12127528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines.
    Tuckman M; Petersen PJ; Projan SJ
    Microb Drug Resist; 2000; 6(4):277-82. PubMed ID: 11272255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetracyclines: antibiotic action, uptake, and resistance mechanisms.
    Schnappinger D; Hillen W
    Arch Microbiol; 1996 Jun; 165(6):359-69. PubMed ID: 8661929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of a tetracycline-platinum (II) complex active against resistant bacteria.
    Chartone-Souza E; Loyola TL; Bucciarelli-Rodriguez M; Menezes MA; Rey NA; Pereira-Maia EC
    J Inorg Biochem; 2005 May; 99(5):1001-8. PubMed ID: 15833322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains.
    McMurry LM; Cullinane JC; Levy SB
    Antimicrob Agents Chemother; 1982 Nov; 22(5):791-9. PubMed ID: 6758689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semisynthetic Analogues of Anhydrotetracycline as Inhibitors of Tetracycline Destructase Enzymes.
    Markley JL; Fang L; Gasparrini AJ; Symister CT; Kumar H; Tolia NH; Dantas G; Wencewicz TA
    ACS Infect Dis; 2019 Apr; 5(4):618-633. PubMed ID: 30835428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines.
    Rasmussen BA; Gluzman Y; Tally FP
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1658-60. PubMed ID: 7526784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936).
    Hirata T; Saito A; Nishino K; Tamura N; Yamaguchi A
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2179-84. PubMed ID: 15155219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of tetracyclines and efflux pump inhibitors.
    Rothstein DM; McGlynn M; Bernan V; McGahren J; Zaccardi J; Cekleniak N; Bertrand KP
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1624-9. PubMed ID: 8215274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter.
    Someya Y; Yamaguchi A; Sawai T
    Antimicrob Agents Chemother; 1995 Jan; 39(1):247-9. PubMed ID: 7695316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeation of tetracyclines through membranes of liposomes and Escherichia coli.
    Sigler A; Schubert P; Hillen W; Niederweis M
    Eur J Biochem; 2000 Jan; 267(2):527-34. PubMed ID: 10632722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance.
    Speer BS; Shoemaker NB; Salyers AA
    Clin Microbiol Rev; 1992 Oct; 5(4):387-99. PubMed ID: 1423217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetracycline resistance determinants from groups A to D vary in their ability to confer decreased accumulation of tetracycline derivatives by Escherichia coli.
    Chopra I; Shales S; Ball P
    J Gen Microbiol; 1982 Apr; 128(4):689-92. PubMed ID: 6750037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.